Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Patient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies.

Foltz LP, Clegg DO.

Prog Retin Eye Res. 2018 Sep 11. pii: S1350-9462(18)30009-0. doi: 10.1016/j.preteyeres.2018.09.002. [Epub ahead of print] Review.

2.

Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks.

Grimes M, Hall B, Foltz L, Levy T, Rikova K, Gaiser J, Cook W, Smirnova E, Wheeler T, Clark NR, Lachmann A, Zhang B, Hornbeck P, Ma'ayan A, Comb M.

Sci Signal. 2018 May 22;11(531). pii: eaaq1087. doi: 10.1126/scisignal.aaq1087.

PMID:
29789295
3.
4.

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.

Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, Coskun T, Hamang MJ, Sindelar DK, Ballman KK, Foltz LA, Muppidi A, Alsina-Fernandez J, Barnard GC, Tang JX, Liu X, Mao X, Siegel R, Sloan JH, Mitchell PJ, Zhang BB, Gimeno RE, Shan B, Wu X.

Nat Med. 2017 Oct;23(10):1215-1219. doi: 10.1038/nm.4393. Epub 2017 Aug 28.

PMID:
28846098
5.

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey.

Harrison CN, Koschmieder S, Foltz L, Guglielmelli P, Flindt T, Koehler M, Mathias J, Komatsu N, Boothroyd RN, Spierer A, Perez Ronco J, Taylor-Stokes G, Waller J, Mesa RA.

Ann Hematol. 2017 Oct;96(10):1653-1665. doi: 10.1007/s00277-017-3082-y. Epub 2017 Aug 5.

6.

5-Flurouracil disrupts nuclear export and nuclear pore permeability in a calcium dependent manner.

Higby KJ, Bischak MM, Campbell CA, Anderson RG, Broskin SA, Foltz LE, Koper JA, Nickle AC, Resendes KK.

Apoptosis. 2017 Mar;22(3):393-405. doi: 10.1007/s10495-016-1338-y.

PMID:
28000054
7.

Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.

Mascarenhas JO, Talpaz M, Gupta V, Foltz LM, Savona MR, Paquette R, Turner AR, Coughlin P, Winton E, Burn TC, O'Neill P, Clark J, Hunter D, Assad A, Hoffman R, Verstovsek S.

Haematologica. 2017 Feb;102(2):327-335. doi: 10.3324/haematol.2016.151126. Epub 2016 Oct 27.

8.

Laboratory Investigation of Myeloproliferative Neoplasms (MPNs):  Recommendations of the Canadian Mpn Group.

Busque L, Porwit A, Day R, Olney HJ, Leber B, Éthier V, Sirhan S, Foltz L, Prchal J, Kamel-Reid S, Karsan A, Gupta V.

Am J Clin Pathol. 2016 Oct;146(4):408-22. doi: 10.1093/ajcp/aqw131. Review.

PMID:
27686169
9.

The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies.

Gupta V, Harrison C, Hexner EO, Al-Ali HK, Foltz L, Montgomery M, Sun W, Gopalakrishna P, Kantarjian H, Verstovsek S.

Haematologica. 2016 Dec;101(12):e482-e484. Epub 2016 Sep 1. No abstract available.

10.

Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome.

Williamson BT, Foltz L, Leitch HA.

Hematol Rep. 2016 May 10;8(2):6480. doi: 10.4081/hr.2016.6480. eCollection 2016 May 10.

11.

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial.

Al-Ali HK, Griesshammer M, le Coutre P, Waller CF, Liberati AM, Schafhausen P, Tavares R, Giraldo P, Foltz L, Raanani P, Gupta V, Tannir B, Ronco JP, Ghosh J, Martino B, Vannucchi AM.

Haematologica. 2016 Sep;101(9):1065-73. doi: 10.3324/haematol.2016.143677. Epub 2016 May 31.

12.

Impact of ruxolitinib treatment on the hemoglobin dynamics and the negative prognosis of anemia in patients with myelofibrosis.

Al-Ali HK, Stalbovskaya V, Gopalakrishna P, Perez-Ronco J, Foltz L.

Leuk Lymphoma. 2016 Oct;57(10):2464-7. doi: 10.3109/10428194.2016.1146950. Epub 2016 Feb 25. No abstract available.

PMID:
26916563
13.

Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.

Sirhan S, Busque L, Foltz L, Grewal K, Hamm C, Laferriere N, Laneuville P, Leber B, Liew E, Olney HJ, Prchal J, Porwit A, Gupta V.

Clin Lymphoma Myeloma Leuk. 2015 Dec;15(12):715-27. doi: 10.1016/j.clml.2015.07.650. Epub 2015 Aug 7.

PMID:
26433906
14.

Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts.

Palacios-Moreno J, Foltz L, Guo A, Stokes MP, Kuehn ED, George L, Comb M, Grimes ML.

PLoS Comput Biol. 2015 Apr 17;11(4):e1004130. doi: 10.1371/journal.pcbi.1004130. eCollection 2015 Apr.

15.

Apoptosis-linked gene-2 (ALG-2)/Sec31 interactions regulate endoplasmic reticulum (ER)-to-Golgi transport: a potential effector pathway for luminal calcium.

Helm JR, Bentley M, Thorsen KD, Wang T, Foltz L, Oorschot V, Klumperman J, Hay JC.

J Biol Chem. 2014 Aug 22;289(34):23609-28. doi: 10.1074/jbc.M114.561829. Epub 2014 Jul 8.

16.

Patients' and physicians' roles in detecting recurrent Hodgkin lymphoma following complete remission.

Bestawros A, Foltz L, Srour N, Savage KJ, Connors JM.

Ann Oncol. 2013 May;24(5):1359-63. doi: 10.1093/annonc/mds606. Epub 2012 Dec 9.

PMID:
23230136
17.

Emerging therapeutic options for myelofibrosis: a Canadian perspective.

Gupta V, Foltz L, Sirhan S, Busque L, Turner AR.

Am J Blood Res. 2012;2(3):170-86. Epub 2012 Sep 23.

18.

Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis.

Leitch HA, Chan C, Leger CS, Foltz LM, Ramadan KM, Vickars LM.

Leuk Res. 2012 Nov;36(11):1380-6. doi: 10.1016/j.leukres.2012.08.001. Epub 2012 Aug 24.

PMID:
22921191
19.

Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era.

Ambler KL, Vickars LM, Leger CS, Foltz LM, Montaner JS, Harris M, Dias Lima V, Leitch HA.

Adv Hematol. 2012;2012:910954. doi: 10.1155/2012/910954. Epub 2012 May 28.

20.

Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, and matrix metalloproteinases 1, 3, and 9 in hypertrophied ligamentum flavum.

Lakemeier S, Schofer MD, Foltz L, Schmid R, Efe T, Rohlfs J, Fuchs-Winkelmann S, El-Zayat BF, Paletta JR, Foelsch C.

J Spinal Disord Tech. 2013 Oct;26(7):400-6. doi: 10.1097/BSD.0b013e3182495b88.

PMID:
22323068
21.

Increased expression of CD44 in hypertrophied ligamentum flavum and relevance of splice variants CD44v5 and CD44v6.

Lakemeier S, Schmid R, Foltz L, Rohlfs J, Fuchs-Winkelmann S, Efe T, Foelsch C, Paletta JR.

Acta Neurochir (Wien). 2012 Feb;154(2):359-65; discussion 365. doi: 10.1007/s00701-011-1206-z. Epub 2011 Nov 4.

PMID:
22052472
22.

Published guidelines versus real-life practice in the diagnosis and treatment of essential thrombocythemia.

Peterson EA, Zypchen L, Lee VH, Nitta J, Foltz LM.

Am J Hematol. 2011 Sep;86(9):792-4. doi: 10.1002/ajh.22094. Epub 2011 Jul 29. No abstract available.

23.

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.

Leitch HA, Chase JM, Goodman TA, Ezzat H, Rollins MD, Wong DH, Badawi M, Leger CS, Ramadan KM, Barnett MJ, Foltz LM, Vickars LM.

Hematol Oncol. 2010 Mar;28(1):40-8. doi: 10.1002/hon.902.

PMID:
19557769
24.

Hodgkin's lymphoma in adolescents.

Foltz LM, Song KW, Connors JM.

J Clin Oncol. 2006 Jun 1;24(16):2520-6.

PMID:
16735704
25.

Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine.

Foltz LM, Dalal BI, Wadsworth LD, Broady R, Chi K, Eisenhauer E, Kobayashi K, Kollmannsburger C.

Am J Hematol. 2006 Mar;81(3):210-1.

26.

Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia.

Kaiser S, Foltz LA, George CA, Kirkwood SC, Bemis KG, Lin X, Gelbert LM, Nisenbaum LK.

Neurobiol Dis. 2004 Jun;16(1):220-35.

PMID:
15207279
27.

Inconsistency of fetal trophoblast cells in first trimester maternal peripheral blood prevents non-invasive fetal testing using this cell target.

Schueler PA, Yamanishi DT, Pearson J, Lee Y, Wu X, Hashima S, Madlansacay MR, Cain CA, Collarini EJ, Foltz L, Mahoney W.

Placenta. 2001 Sep-Oct;22(8-9):702-15.

PMID:
11597190
28.

Enrichment and identification of fetal trophoblast cells from first trimester maternal cervical lavage and uterine blood specimens.

Schueler PA, Yamanishi DT, Collarini EJ, Pearson J, Lee Y, Cain CA, Edwards J, Foltz L, Wu X, Mahoney W.

Placenta. 2001 Sep-Oct;22(8-9):688-701.

PMID:
11597189
29.

Cloning and characterization of human erythroid membrane-associated protein, human ERMAP.

Xu H, Foltz L, Sha Y, Madlansacay MR, Cain C, Lindemann G, Vargas J, Nagy D, Harriman B, Mahoney W, Schueler PA.

Genomics. 2001 Aug;76(1-3):2-4.

PMID:
11549310
30.

Identification of differentially expressed mRNAs in human fetal liver across gestation.

Malhotra K, Luehrsen KR, Costello LL, Raich TJ, Sim K, Foltz L, Davidson S, Xu H, Chen A, Yamanishi DT, Lindemann GW, Cain CA, Madlansacay MR, Hashima SM, Pham TL, Mahoney W, Schueler PA.

Nucleic Acids Res. 1999 Feb 1;27(3):839-47.

31.

Interaction and effect of annealing temperature on primers used in differential display RT-PCR.

Malhotra K, Foltz L, Mahoney WC, Schueler PA.

Nucleic Acids Res. 1998 Feb 1;26(3):854-6.

32.

Controlling for general and disease-specific effects in child and family adjustment to chronic childhood illness.

Holden EW, Chmielewski D, Nelson CC, Kager VA, Foltz L.

J Pediatr Psychol. 1997 Feb;22(1):15-27.

PMID:
9019045
33.

A high affinity digoxin-binding protein displayed on M13 is functionally identical to the native protein.

Tang PM, Foltz LA, Mahoney WC, Schueler PA.

J Biol Chem. 1995 Apr 7;270(14):7829-35.

35.

Critical evaluation of tranquilizers.

FOLTZ LM.

J Ky Med Assoc. 1962 Aug;60:733-8. No abstract available.

PMID:
13893870
36.

Report on the Kentucky Commission on Alcoholism.

FOLTZ LM.

J Ky Med Assoc. 1961 Nov;59:1069-74. No abstract available.

PMID:
13893871
37.

Psychiatric aspects of menopause.

FOLTZ LM.

Ky Med J. 1947 Jun;45(6):212. No abstract available.

PMID:
20252047
38.

Symposium on the menopause.

COLEMAN FD, JOHNSON WO, FOLTZ LM.

Ky Med J. 1947 Jun;45(6):207-13. No abstract available.

PMID:
20252045
39.

Correlation of electrical and mechanical events in the intestinal lumen of unanesthetized dogs.

YOUMANS WB, FOLTZ L.

Fed Proc. 1946;5(1 Pt 2):117. No abstract available.

PMID:
21023572

Supplemental Content

Support Center